Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging facilities with efficient operating models primarily in the upscale segment of the lodging industry. As of February 24, 2025, the Company's portfolio consisted of 97 assets, 53 of which are wholly owned, with a total of 14,553 guestrooms located in 25 states.

Summit Hotel Properties Inc.

American International Group ( ($AIG) ) has issued an announcement. American International Group, Inc. (AIG) has finalized the documentation relate...

AIG Finalizes Agreement with John Neal

KBW analyst Meyer Shields maintained a Buy rating on American International Group on November 7 and set a price target of $91.00. Shields covers th...

KBW Sticks to Their Buy Rating for American International Group (AIG)

The latest update is out from Amplia Therapeutics ( ($AU:ATX) ). Amplia Therapeutics Limited has announced the issuance of 480,769 unquoted equity ...

Amplia Therapeutics Issues New Equity Securities

In a report released yesterday, Ryan Tunis from Cantor Fitzgerald reiterated a Hold rating on American International Group, with a price target of ...

American International Group (AIG) Gets a Hold from Cantor Fitzgerald

KeyBanc analyst Matthew Gillmor CFA maintained a Hold rating on InnovAge Holding today. The company’s shares closed yesterday at $4.84. According t...

KeyBanc Sticks to Its Hold Rating for InnovAge Holding (INNV)

In a report released today, Alex Scott from Barclays maintained a Buy rating on American International Group, with a price target of $95.00. The co...

Barclays Remains a Buy on American International Group (AIG)

In a report released today, Namita Samtani from Barclays maintained a Buy rating on ING GROEP, with a price target of €23.20. The company’s shares ...

Barclays Reaffirms Their Buy Rating on ING GROEP (0RIC)

ING Groep ( ($ING) ) just unveiled an announcement. On October 30, 2025, ING Group announced the completion of the 2025 Supervisory Review and Eval...

ING Groep Completes 2025 SREP Process with ECB

In a report released today, Delphine Lee from J.P. Morgan maintained a Buy rating on ING GROEP, with a price target of €25.40. The company’s shares...

J.P. Morgan Sticks to Their Buy Rating for ING GROEP (0RIC)

Kepler Capital analyst Benoit Petrarque maintained a Buy rating on ING GROEP on October 30 and set a price target of €27.70. The company’s shares c...

ING GROEP (0RIC) Receives a Rating Update from a Top Analyst

Amplia Therapeutics ( ($AU:ATX) ) has shared an announcement. Amplia Therapeutics has commenced trading on the U.S. OTCQB Venture Market, enhancing...

Amplia Therapeutics Expands U.S. Market Presence with OTCQB Listing

An update from ING Groep ( ($ING) ) is now available. On October 29, 2025, ING announced the appointment of Ida Lerner as the new Chief Financial O...

ING Appoints Ida Lerner as New CFO

Amplia Therapeutics ( ($AU:ATX) ) just unveiled an update. Amplia Therapeutics has received a $3.77 million R&D tax rebate from the Australian Tax ...

Amplia Therapeutics Secures $3.77 Million R&D Tax Rebate to Boost Cancer Trials

An announcement from InnoCan Pharma ( ($TSE:INNO) ) is now available. Innocan Pharma announced its participation in the 2025 ThinkEquity Conference...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INN	$5.14	+5.98%	776.10K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INN	$5.14	+6.0%	776.10K
3
4
5
6

INN

INN

Get Summit Hotel Properties Inc. Data in Excel

Get Summit Hotel Properties Inc. Data in Excel